Back to search
FDAFDA · Food and drugs·Recall number D-206-2013

METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 (NDC 0409-7811-24)

Published March 27, 2013 · Recall initiated: February 15, 2013

Summary

FDA records drug Class II recall D-206-2013, published March 27, 2013 and initiated February 15, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 567,624 bags; Lot: Lot code 12-074-JT Exp 12/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide.
Lot
Lot code 12-074-JT Exp 12/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was METRONIDazole Injection, USP 500 mg (5 mg/mL), 100 mL Bag, Rx only, Hospira, Inc. Lake Forest, IL 60045 (NDC 0409-7811-24) recalled?

Yes. FDA published recall D-206-2013 on March 27, 2013. Reported hazard: Lack of Assurance of Sterility: There is the potential for the solution to leak from the administrative port to the fill tube seal.

What should I do if I have this product?

Voluntary: Firm initiated · Letter